Artwork

Content provided by Caris Molecular Minute Podcast Series and Dr. Chadi Nabhan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Caris Molecular Minute Podcast Series and Dr. Chadi Nabhan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Interview with Dr. Stephen Liu: An In-depth Look at the ADAURA Trial

32:19
 
Share
 

Manage episode 367329214 series 2982543
Content provided by Caris Molecular Minute Podcast Series and Dr. Chadi Nabhan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Caris Molecular Minute Podcast Series and Dr. Chadi Nabhan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu, Associate Professor of Medicine at Georgetown University and Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. Together they discuss the updated results of the ADAURA Trial presented at this year's ASCO meeting which demonstrated the overall survival benefit when adding osimertinib versus placebo in patients with completely resected stage IB-IIIA NSCLC, with/without adjuvant chemotherapy. For more information, please visit: www.CarisLifeSciences.com
  continue reading

60 episodes

Artwork
iconShare
 
Manage episode 367329214 series 2982543
Content provided by Caris Molecular Minute Podcast Series and Dr. Chadi Nabhan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Caris Molecular Minute Podcast Series and Dr. Chadi Nabhan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Stephen Liu, Associate Professor of Medicine at Georgetown University and Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. Together they discuss the updated results of the ADAURA Trial presented at this year's ASCO meeting which demonstrated the overall survival benefit when adding osimertinib versus placebo in patients with completely resected stage IB-IIIA NSCLC, with/without adjuvant chemotherapy. For more information, please visit: www.CarisLifeSciences.com
  continue reading

60 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide